Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

"Medicare Exchange" Proposal From Healthcare Leadership Council Could Deter Threat Of Part B Drug Payment Reductions

This article was originally published in The Pink Sheet Daily

Executive Summary

Healthcare Leadership Council sends "super committee" recommendations, including Medicare reforms, that could save $410 billion in health care costs.

You may also be interested in...



Medicare Part D Mandatory Rebates Advised By Budget Experts At Super Committee Hearing

Hearing witnesses also urge the committee to endorse an overhaul of Medicare that allows private plans to compete with the fee-for-service program through a federal exchange.

Medicare Part D Mandatory Rebates Advised By Budget Experts At Super Committee Hearing

Hearing witnesses also urge the committee to endorse an overhaul of Medicare that allows private plans to compete with the fee-for-service program through a federal exchange.

Part D Rebates Would Contribute More Than Half Of Medicare Savings In White House Plan

Plan seeks to cut Medicare costs by a total of $248 billion over 10 years, with mandatory rebates in Part D contributing $135 billion.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS072769

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel